Gamida Cell Ltd.

Gamida Cell Ltd. is a pioneering biopharmaceutical company focused on developing potentially curative cell therapies for patients with cancer, particularly those with hematologic malignancies. Utilizing their proprietary nicotinamide (NAM) technology, Gamida Cell works to enhance and expand cells to create allogeneic cell therapy products. The company's mission centers on patient needs, aiming to transform lives with innovative therapies that offer hope for a better quality of life. With a commitment to research, development, and advocacy, Gamida Cell brings together a dedicated team of experts in cell therapy manufacturing and commercialization, enhancing the future of cancer care.